Cite
HARVARD Citation
Burlacu, R. et al. (2021). No evidence of tocilizumab treatment efficacy for severe to critical SARS-CoV2 infected patients. Medicine. 100 (21), p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Burlacu, R. et al. (2021). No evidence of tocilizumab treatment efficacy for severe to critical SARS-CoV2 infected patients. Medicine. 100 (21), p. . [Online].